Anaesthesia for patients with mood disorders

Current Opinion in Anaesthesiology

Volumn 18, Issue 3, 2005, Pages 333-338

  De Baerdemaeker, Luc ^a   Audenaert, Kurt ^a   Peremans, Kathelijne ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Antidepressants; Drug discontinuation; Electroconvulsive therapy; Mood disorders; Serotonin syndrome

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALMOTRIPTAN; AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ANTIRETROVIRUS AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BIGUANIDE DERIVATIVE; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; CORTICOSTEROID; CYPROHEPTADINE; DIGOXIN; DOPAMINE RECEPTOR BLOCKING AGENT; DULOXETINE; ERYTHROMYCIN; ESCITALOPRAM; FENTANYL; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; INSULIN; IPROCLOZIDE; KAVA EXTRACT; KETAMINE; LAMOTRIGINE; LINEZOLID; LITHIUM; LORAZEPAM; METHOHEXITAL; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PAROXETINE; PHENELZINE; PROPOFOL; PROPRANOLOL; QUETIAPINE; REBOXETINE; REMIFENTANIL; RISPERIDONE; RIZATRIPTAN; SELEGILINE; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEVOFLURANE; SULFONYLUREA DERIVATIVE; SUMATRIPTAN; SUXAMETHONIUM; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALERIAN; VALPROIC ACID; VENLAFAXINE; WARFARIN; ZOLMITRIPTAN;

ANESTHESIOLOGICAL TECHNIQUES; ANXIETY DISORDER; BIPOLAR DISORDER; BISPECTRAL INDEX; BLEEDING DISORDER; CARDIOTOXICITY; CONFUSION; DEPRESSION; DRUG CLEARANCE; DRUG EFFECT; DRUG POTENTIATION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LOW DRUG DOSE; MOOD DISORDER; POSTOPERATIVE PAIN; PREMEDICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SEROTONIN SYNDROME; STRESS; THERMOREGULATION; THROMBOCYTOPENIA;

EID: 20444382751     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000169243.03754.85     Document Type: Review

References (37)

1. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109:21-27.
2. Cavanagh J, Smyth R, Goodwin GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand 2004; 109:91-95.
3. Yerevanian BI, Koek RJ, Feusner JD, et al. Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr Scand 2004; 110:452-458.
4. Schalzberg AF. Antidepressant discontinuation syndrome: An update on serotonin reuptake inhibitors - Introduction. J Clin Psychiatry 1997; 58:3-4.
5. Kudoh A, Katagai H, Takazawa T. Antidepressant treatment for chronic depressed patients should not be discontinued prior to anesthesia. Can J Anaesth 2002; 49:132-136.
6. Ali S, Milev R. Switch to mania upon discontinuation of antidepressants in patients with mood disorders. A review of the literature. Can J Psychiatry 2000; 48:258-264.
7. Kudoh A, Takase H, Takazawa T. Chronic treatment with antidepressants decreases intraoperative core hypothermia. Anesth Analg 2003; 97:275-279.
8. Kudoh A, Takase H, Takazawa T. Chronic treatment with antipsychotics enhances intraoperative core hypothermia. Anesth Analg 2004; 98:111-115. In this paper, the authors showed that in patients on antipsychotics, core temperatures are lower. Hypothermia and shivering are still important risk factors in the postoperative period.
9. Schlienger RG, Fischer LM, Jick H, Meier CR. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 2004; 27:1157-1165. Depressed patients have a higher risk of coronary artery disease. Patients with acute myocardial infarction frequently suffer from depression. This article gives a good review on the advantages and indications of SSRIs with their antiplatelet activity.
10. Bpharm SR, Fortier LP. Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine. Can J Anaesth 2003; 50:32-35.
11. Nath S, Rudra A. Herbal medicines and their importance to anaesthesiologists. Ind J Anaesth 2002; 46:224-225.
12. Roberge J. Anaesthesiologists warned on effect of herbal medicines taken prior to surgery. Crit Care Int 1999; 9:1-4.
13. Zollman C, Vickers A. The ABC of complementary medicine. BMJ 1999; 319:1051-1053.
14. Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE. Anesthetic considerations of the herbal, kava. J Clin Anesth 2004; 16:305-311.
15. Jacobson M, Siverglade B. Functional foods: health boon or quackery? BMJ 1999; 319:205-206.
16. Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42:877-888. This paper reviews studies on the accuracy of ECG and tricyclic antidepressant concentration as prognostic indicators of the risk of seizures, ventricular arrhythmia or death in patients with tricyclic antidepressant overdose.
17. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277-285. The objective of this study is to determine the effect of SSRIs in overdose, as a group, and the relative toxicity of five different SSRIs.
18. Bravo AER, Egger SS, Crespo S, et al. Lithium intoxication as a result of an interaction with rofecoxib. Ann Pharmacother 2004; 38:1189-1193.
19. Rose D, Wykes T, Leese M, et al. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003; 326:1363-1365.
20. Gomez F, Cantini O, Valat P, et al. Anaesthesia for electroconvulsive therapy. Ann Francais Anesth Reanimation 2001; 20:187-195.
21. Gonzalez-Pinto A, Gutierrez M, Gonzalez N, et al. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression. J Neuropsychiatry Clin Neurosci 2002; 14:206-209.
22. Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy - Implications for drug choice and patient management. CNS Drugs 2002; 16:229-247.
23. Hertzman M. Ect and neuroleptics as primary-treatment for schizophrenia. Biol Psychiatry 1992; 31:217-220.
24. White PF, Rawal S, Recart A, et al. Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy? Anesth Analg 2003; 96:1636-1639.
25. Ochiai R, Yamada T, Kiyama S, et al. Bispectral index as an indicator of seizure inducibility in electroconvulsive therapy under thiopental anesthesia. Anesth Analg 2004; 98:1030-1035. According to this study. BIS monitoring can be useful during ECT.
26. Smith DL, Angst MS, Brock-Utne JG, DeBattista C. Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. Acta Anaesthesiol Scand 2003; 47:1064-1066.
27. Wajima Z, Shiga T, Yoshikawa T, et al. Propofol alone, sevoflurane alone, and combined propofol-sevoflurane anaesthesia in electroconvulsive therapy. Anaesth Intens Care 2003; 31:396-400.
28. Sullivan PM, Sinz EH. The use of remifentanil anesthesia for electroconvulsive therapy in patients with high seizure thresholds. J ECT 2004; 20:278.
29. Nishihara F, Ohkawa M, Hiraoka H, et al. Benefits of the laryngeal mask for airway management during electroconvulsive therapy. J ECT 2003; 19:211-216.
30. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705-713.
31. Kolecki P. Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks. J Toxicol Clin Toxicol 1997; 35:211-212.
32. Ranta SOV, Laurila R, Saario J, et al. Awareness with recall during general anesthesia: incidence and risk factors. Anesth Analg 1998; 86:1084-1089.
33. Tolksdorf W. Preoperative stress: scientific and therapeutical approaches. Anasthesiol Intensivmed Notfallmed Schmerzther 1997; 32:S318-S324.
34. Kollner V, Oster O, Gress H, et al. Consultation or liaison psychotherapy service - what difference does it make for an outpatient pain clinic? Anaesthesist 2002; 51:897-903.
35. Kudoh A, Katagai H, Takazawa T. Increased postoperative pain scores in chronic depression patients who take antidepressants. J Clin Anesth 2002; 14:421-425.
36. Kudoh A, Takahira Y, Katagai H, Takazawa T. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 2002; 95:114-118.
37. Kudoh A, Katagai H, Takazawa T. Anesthesia with ketamine, propofol, and fentanyl decreases the frequency of postoperative psychosis emergence and confusion in schizophrenic patients. J Clin Anesth 2002; 14:107-110.